Authors: REGINSTER JYL LECART MP

Citation: Jyl. Reginster et Mp. Lecart, EFFICACY AND SAFETY OF DRUGS FOR PAGETS-DISEASE OF BONE, Bone, 17(5), 1995, pp. 485-488

Authors: REGINSTER JY DEROISY R LECART MP SARLET N ZEGELS B JUPSIN I DELONGUEVILLE M FRANCHIMONT P

Citation: Jy. Reginster et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF INTERMITTENT NASAL SALMON-CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL LUMBAR SPINE BONE LOSS, The American journal of medicine, 98(5), 1995, pp. 452-458

Authors: REGINSTER JY DENIS D DEROISY R LECART MP DELONGUEVILLE M ZEGELS B SARLET N NOIRFALISSE P FRANCHIMONT P

Citation: Jy. Reginster et al., LONG-TERM (3 YEARS) PREVENTION OF TRABECULAR POSTMENOPAUSAL BONE LOSSWITH LOW-DOSE INTERMITTENT NASAL SALMON-CALCITONIN, Journal of bone and mineral research, 9(1), 1994, pp. 69-73

Authors: REGINSTER JY ETHGEN D BARBIER A GEUSENS P LECART MP CHAPPARD D DEVERNEJOUL MC ZEGELS B FRANCHIMONT P

Citation: Jy. Reginster et al., EVIDENCE THAT TILUDRONATE IS AN INTERESTING PERSPECTIVE FOR PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS, Journal of bone and mineral research, 8, 1993, pp. 190000326-190000326

Authors: REGINSTER JY DEROISY R LECART MP ZEGELS B SARLET N DELONGUEVILLE M ALBERT A FRANCHIMONT P

Citation: Jy. Reginster et al., NASAL SALMON-CALCITONIN FOR PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS - A DOSE-RANGING PLACEBO-CONTROLLED STUDY, Journal of bone and mineral research, 8, 1993, pp. 190000340-190000340